Chester County News and Community Website
WASHINGTON, D.C. — Federal health officials have pushed back key deadlines for a new Medicaid drug pricing initiative after strong interest from pharmaceutical manufacturers and state programs.
CMS Extends Drug Pricing Program Deadlines Amid Demand Read More
WASHINGTON, D.C. — American patients could see significantly lower prescription drug costs under a new federal agreement with Regeneron that ties U.S. prices to the lowest rates paid in other …
Drug Prices Could Drop Sharply Under New Federal Deal Read More WASHINGTON, D.C. — Federal health officials announced that manufacturers of 15 high-cost prescription drugs have agreed to participate in the next round of Medicare drug price negotiations, a program designed …
Drugmakers Agree to Join Next Round of Medicare Price Negotiations Read More
WASHINGTON, D.C. — In a sweeping bid to upend how Americans pay for healthcare, Donald J. Trump on Thursday unveiled what he is calling The Great Healthcare Plan—a far-reaching proposal …
Trump Bets Big on Healthcare: A Radical Plan to Cut Costs and Pay Patients Directly Read More
WASHINGTON, D.C. — President Donald Trump and British Prime Minister Keir Starmer have reached an agreement in principle on pharmaceutical pricing that U.S. officials say could reshape the global drug …
U.S., U.K. Strike Drug Pricing Deal Aimed at Ending Transatlantic Imbalance Read More
PHILADELPHIA, PA — The City of Philadelphia has launched a sweeping lawsuit against some of the nation’s largest pharmacy benefit managers and insulin manufacturers, accusing them of orchestrating a pricing …
Philadelphia Sues PBMs, Drugmakers Over Insulin Prices That Skyrocketed Read More
WASHINGTON, D.C. — In a move that could reshape how obesity and metabolic disease are treated nationwide, federal health officials unveiled a new strategy to bring high-profile GLP-1 weight-loss drugs …
Weight-Loss Drugs Could Hit Medicare for $50 as CMS Upends Coverage Rules Read More
WASHINGTON, D.C. — President Donald J. Trump on Friday announced a new agreement with pharmaceutical company AstraZeneca aimed at lowering prescription drug costs and strengthening U.S. manufacturing, part of a …
Trump Administration, AstraZeneca Reach Deal to Cut Drug Prices and Expand U.S. Investment Read More WASHINGTON, D.C. — The Centers for Medicare & Medicaid Services (CMS) released its final guidance for the third cycle of the Medicare Drug Price Negotiation Program on Tuesday, introducing major …
CMS Finalizes New Medicare Drug Price Rules, Expands Rare Disease Protections Read More
WASHINGTON, D.C. — The Departments of Labor, Health and Human Services, and the Treasury have announced new measures to advance healthcare price transparency. These actions, initiated on Thursday, May 22, …
Know What You Pay: Bold Federal Push for Real Healthcare Price Transparency Read More